Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions

Affiliations

¹ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK. o.rominiyi@sheffield.ac.uk.
² Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. o.rominiyi@sheffield.ac.uk.
³ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK.
⁴ Department of Clinical Oncology, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁵ Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁶ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK. s.collis@sheffield.ac.uk.

^# Contributed equally.

Published Erratum

Ola Rominiyi et al. Br J Cancer. 2021 Aug.

. 2021 Aug;125(4):623.

doi: 10.1038/s41416-021-01451-5.

¹ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK. o.rominiyi@sheffield.ac.uk.
² Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. o.rominiyi@sheffield.ac.uk.
³ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK.
⁴ Department of Clinical Oncology, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁵ Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
⁶ Weston Park Cancer Centre, Department of Oncology & Metabolism, The University of Sheffield Medical School, Sheffield, UK. s.collis@sheffield.ac.uk.

^# Contributed equally.

No abstract available

Erratum for

Tumour treating fields therapy for glioblastoma: current advances and future directions.
Rominiyi O, Vanderlinden A, Clenton SJ, Bridgewater C, Al-Tamimi Y, Collis SJ. Rominiyi O, et al. Br J Cancer. 2021 Feb;124(4):697-709. doi: 10.1038/s41416-020-01136-5. Epub 2020 Nov 4. Br J Cancer. 2021. PMID: 33144698 Free PMC article. Review.